Harnessing Gut Endocrine Cell Plasticity to Restore Insulin Production
Authors:
- Chaïma AyachiCAChaïma Ayachi
- Tiziana NapolitanoTNTiziana Napolitano
- Serena SilvanoSSSerena Silvano
- Sophie Giorgetti-PeraldiSGSophie Giorgetti-Peraldi
- Ahmed MansouriAMAhmed Mansouri
- Raphaël Rapetti-MaussRRRaphaël Rapetti-Mauss
- Hugo FofoHFHugo Fofo
- Valentin LepageVLValentin Lepage
- Laura EtasseLELaura Etasse
- Caroline TreinsCTCaroline Treins
- Loan TranLTLoan Tran
- Patrick CollombatPCPatrick Collombat
Open Access
Abstract
Type 1 diabetes (T1D) results from autoimmune-mediated destruction of pancreatic β-cells, leading to insulin deficiency and chronic hyperglycemia. β-cell replacement represents a promising therapeutic strategy, yet the identification of a sustainable and immune-compatible cell source remains a major challenge. Here, we explore the potential of the gastrointestinal (GI) epithelium as an alternative source of β-cells through in vivo cellular reprogramming. Given the large size and highly regenerative nature of the GI tract, partial reprogramming could provide a renewable source of insulin-producing (insulin+) cells. We demonstrate that ectopic expression of Pax4 is sufficient to convert gut endocrine L-cells into insulin+ cells in vivo. Phenotypic analyses reveal that these gut-derived cells express key β-cell markers, components of the glucose-sensing machinery, and properly process proinsulin into mature insulin. Functional studies using organoids derived from Pax4-expressing gut epithelium further demonstrate that these cells display glucose-responsive insulin secretion. Collectively, our findings highlight the plasticity of gut endocrine cells and support the feasibility of generating β-like cells from the GI epithelium, providing a potential avenue for the development of alternative cell-based therapies for T1D.Keywords
Funding Information
- Juvenile Diabetes Research Foundation Australia (2-SRA-2017-416-S-B)
- Juvenile Diabetes Research Foundation Australia (2-SRA-2017-417-S-B)
- Agence Nationale pour la Recherche (ANR-16-CE18-0005-01)
- Agence Nationale pour la Recherche (ANR-17-CE14-0034)
- Labex Signalife (ANR-11-LABX-0028-01)
- IDEX UCA JEDI (ANR-15-IDEX-01)
This publication has 49 references indexed in Scilit:
- Harnessing gut cells for functional insulin production: Strategies and challengesBiotechnology Notes, 2023
- Identification of Enteroendocrine Regulators by Real-Time Single-Cell Differentiation MappingCell, 2019
- Insulin Secretion Depends on Intra-islet Glucagon SignalingCell Reports, 2018
- FOXO transcription factors at the interface of metabolism and cancerInternational Journal of Cancer, 2017
- De Novo Formation of Insulin-Producing “Neo-β Cell Islets” from Intestinal CryptsCell Reports, 2014
- Pancreatic β Cell Dedifferentiation as a Mechanism of Diabetic β Cell FailureCell, 2012
- The Ectopic Expression of Pax4 in the Mouse Pancreas Converts Progenitor Cells into α and Subsequently β CellsCell, 2009
- Glucose Sensing in L Cells: A Primary Cell StudyCell Metabolism, 2008
- FoxO1 protects against pancreatic β cell failure through NeuroD and MafA inductionCell Metabolism, 2005
- Origin, differentiation and renewal of the four main epithelial cell types in the mouse small intestine V. Unitarian theory of the origin of the four epithelial cell typesJournal of Anatomy, 1974